Company Overview

Company name: Lobe Sciences (CNQ: LOBE)
Description: Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications. The company also owns acquired brands, intellectual property, and leases office and production premises to a cannabis processor and retailer. It derives its revenues from the cannabis industry in the State of Washington, U.S.A.
Year founded: 2010
Parent company:
Industry: Business Products and Services (B2B) | Group: | Code:
City: Vancouver
State: British Columbia
Country: Canada

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue/Not Profitable
Ownership: Publicly Held
Exchange: CNQ
Ticker: LOBE
Revenue (USD Million): 0,66
Gross profit (USD Million):
Net income (USD Million) -2,55
Enterprise value: 3,83
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: FY 2020
Financing Status:
Number of active investors:
Profile last updated: 29-dic-2020
Last known valuation:
Last known valuation date: